¸ñÀû: Rhinitis is a common inflammatory response of nasal mucosa with
clinical symptoms of rhinorrhea, nasal obstruction, sneezing, and
itching of nose and eyes. Especially, allergic rhinitis affects
25% of
the world¡¯s population and its prevalence continues to increase
annually. Recently, measuring nasal nitric oxide (nNO) becomes a
useful noninvasive secondary method for evaluating severity of
upper
airway inflammation. The aim of this study is to evaluate whether
nNO
reflects the treatment effect. ¹æ¹ý:Levels of nNO were measured from the patients who visited
otorhinolaryngology department for rhinitis symptoms with a NO
analyzer (NIOX VERO) from December 2021 to November 2023. Every
patient received treatment with intranasal corticosteroid spray,
oral
antihistamine and/or oral leukotriene antagonists. Levels of nNO
were
repeatedly measured after the treatment. Total nasal symptoms
score
(TNSS) before and after the treatment were evaluated and the
difference between the score was measured. Laboratory tests,
including
serum total immunoglobulin E (IgE), blood eosinophil percent and
count, and skin prick test were performed at the initial visit.
Total
nasal symptom score (TNSS) and quality of life (QOL)
questionnaire
were evaluated before and after the treatment. °á°ú:A total of 46 patients were included in this study. According to skin
prick test, 39 patients were considered as allergic rhinitis (AR,
84.8%) and 7 patients were considered as non-allergic rhinitis (NAR,
15.2%). TNSS and score of QOL questionnaire after the treatment were
significantly decreased compared to those before the treatment (TNSS
p<0.001, QOL questionnaire p=0.002). The difference between the nNO
and TNSS significantly shows positive correlation (p=0.045). Pre-
treatment blood eosinophil percent was significantly higher in
patients with larger nNO difference (p=0.022). There was no
significant correlation between the nNO difference and pre-treatment
serum total IgE, but it tended to be correlated (p = 0.887). According
to QOL questionnaire, sleep disturbance, generalized symptoms,
practical problems, nasal symptoms, and ocular symptoms categories
showed significant correlation to nNO difference (p<0.05). Activity
limitation and emotional problems categories did not significantly be
related to nNO difference, but still tended to be correlated. Lastly,
pre-treatment TNSS were higher when initial nNO levels were higher,
even it is not significantly correlated. °á·Ð:In this study, the changes in TNSS and QOL score correlated to
the
change in nNO level in rhinitis patients after treatment. As nNO
levels
were considerably decreased after the treatment, nNO may be used
as
objective tool for evaluating treatment effect of rhinitis. |